CUSIP 76155X100 · who reports it, how much, and how much it matters to them
69 of the 720 hedge fund managers we track reported shares of Revolution Medicines, Inc. (Nasdaq: RVMD) on Form 13F for 30 June 2026. Between them they reported USD 7.6bn. The largest position belongs to Farallon Capital Management, at USD 2.5bn. The manager with the most riding on it is Aihc Capital Management, where it is 54.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Farallon Capital Management56 funds on PPLI.com | USD 2.5bn | 11.7% |
| 2 | Baker Bros. Advisors2 funds on PPLI.com | USD 2.1bn | 10.7% |
| 3 | Casdin Capital3 funds on PPLI.com | USD 483m | 24.2% |
| 4 | Avoro Capital Advisors1 fund on PPLI.com | USD 430m | 3.9% |
| 5 | Holocene Advisors2 funds on PPLI.com | USD 255m | 0.6% |
| 6 | Rock Springs Capital Management2 funds on PPLI.com | USD 207m | 10.1% |
| 7 | Two Sigma Investments35 funds on PPLI.com | USD 138m | 0.1% |
| 8 | Logos Global Management1 fund on PPLI.com | USD 131m | 5.6% |
| 9 | Polar Capital LLP26 funds on PPLI.com | USD 129m | 0.3% |
| 10 | Adage Capital Management1 fund on PPLI.com | USD 112m | 0.2% |
| 11 | Citadel Advisors32 funds on PPLI.com | USD 110m | 0.0% |
| 12 | Dafna Capital Management6 funds on PPLI.com | USD 105m | 20.1% |
| 13 | Perceptive Advisors6 funds on PPLI.com | USD 99m | 1.5% |
| 14 | Boxer Capital Management1 fund on PPLI.com | USD 94m | 7.1% |
| 15 | Boothbay Fund Management2 funds on PPLI.com | USD 87m | 1.1% |
| 16 | Aihc Capital Management1 fund on PPLI.com | USD 57m | 54.5% |
| 17 | Marshall Wace LLP84 funds on PPLI.com | USD 46m | 0.0% |
| 18 | Millennium Management6 funds on PPLI.com | USD 40m | 0.0% |
| 19 | Artia Global Partners1 fund on PPLI.com | USD 35m | 6.4% |
| 20 | Samlyn Capital8 funds on PPLI.com | USD 28m | 0.5% |
| 21 | PFM Health Sciences3 funds on PPLI.com | USD 27m | 2.3% |
| 22 | Melqart Asset Management (UK)3 funds on PPLI.com | USD 23m | 2.2% |
| 23 | Eagle Health Investments1 fund on PPLI.com | USD 23m | 3.7% |
| 24 | Zweig-Dimenna Associates3 funds on PPLI.com | USD 23m | 2.0% |
| 25 | Birnam Oak Advisors3 funds on PPLI.com | USD 20m | 3.3% |
| 26 | Atika Capital Management3 funds on PPLI.com | USD 16m | 1.1% |
| 27 | Moore Capital Management7 funds on PPLI.com | USD 15m | 0.2% |
| 28 | Empyrean Capital Partners2 funds on PPLI.com | USD 14m | 0.5% |
| 29 | Orbimed Advisors1 fund on PPLI.com | USD 13m | 0.2% |
| 30 | HighVista Strategies27 funds on PPLI.com | USD 13m | 2.9% |
| 31 | Freestone Grove Partners1 fund on PPLI.com | USD 12m | 0.1% |
| 32 | POINT72 Asset Management17 funds on PPLI.com | USD 11m | 0.0% |
| 33 | Superstring Capital Management1 fund on PPLI.com | USD 9.6m | 6.0% |
| 34 | Burkehill Global Management5 funds on PPLI.com | USD 9.4m | 0.3% |
| 35 | Sona Asset Management (US)1 fund on PPLI.com | USD 8.7m | 0.2% |
| 36 | LMR Partners2 funds on PPLI.com | USD 8.5m | 0.0% |
| 37 | Exoduspoint Capital Management7 funds on PPLI.com | USD 8.2m | 0.1% |
| 38 | The Quarry1 fund on PPLI.com | USD 7.5m | 0.6% |
| 39 | Persistent Asset Partners10 funds on PPLI.com | USD 7.3m | 2.2% |
| 40 | IFM Investors Pty7 funds on PPLI.com | USD 6.6m | 0.0% |
| 41 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 6.4m | 0.0% |
| 42 | Cinctive Capital Management5 funds on PPLI.com | USD 5m | 0.2% |
| 43 | Sphera Funds Management1 fund on PPLI.com | USD 4.2m | 0.5% |
| 44 | Anson Funds Management8 funds on PPLI.com | USD 3.7m | 0.2% |
| 45 | Bronte Capital Management Pty3 funds on PPLI.com | USD 3.5m | 0.4% |
| 46 | Platinum Investment Management11 funds on PPLI.com | USD 3.2m | 0.8% |
| 47 | Tudor Investment Corporation10 funds on PPLI.com | USD 3m | 0.0% |
| 48 | Greenland Capital Management1 fund on PPLI.com | USD 2.6m | 0.3% |
| 49 | Hudson Bay Capital Management8 funds on PPLI.com | USD 2.3m | 0.0% |
| 50 | D. E. Shaw & Co.15 funds on PPLI.com | USD 2.3m | 0.0% |
| 51 | Lighthouse Investment Partners190 funds on PPLI.com | USD 2.2m | 0.1% |
| 52 | Prelude Capital Management9 funds on PPLI.com | USD 2.1m | 0.1% |
| 53 | CIBC Asset Management69 funds on PPLI.com | USD 1.6m | 0.0% |
| 54 | Rangeley Capital6 funds on PPLI.com | USD 1.6m | 1.5% |
| 55 | Sandler Capital Management11 funds on PPLI.com | USD 1.6m | 0.8% |
| 56 | Dark Forest Capital Management2 funds on PPLI.com | USD 1.5m | 0.1% |
| 57 | Engineers Gate Manager1 fund on PPLI.com | USD 1.4m | 0.0% |
| 58 | Capstone Investment Advisors25 funds on PPLI.com | USD 1.3m | 0.0% |
| 59 | Eversept Partners3 funds on PPLI.com | USD 1.3m | 0.1% |
| 60 | Edgestream Partners5 funds on PPLI.com | USD 1.1m | 0.0% |
| 61 | Brevan Howard Capital Management39 funds on PPLI.com | USD 914,000 | 0.0% |
| 62 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 833,000 | 0.1% |
| 63 | Fora Capital1 fund on PPLI.com | USD 818,000 | 0.1% |
| 64 | Verdad Advisers6 funds on PPLI.com | USD 759,000 | 0.7% |
| 65 | Cannon Global Investment Management2 funds on PPLI.com | USD 749,000 | 2.1% |
| 66 | Entrypoint Capital1 fund on PPLI.com | USD 669,000 | 0.2% |
| 67 | Oxford Asset Management LLP2 funds on PPLI.com | USD 384,000 | 0.2% |
| 68 | Jain Global1 fund on PPLI.com | USD 314,000 | 0.0% |
| 69 | Governors Lane1 fund on PPLI.com | USD 153,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Aihc Capital Management | USD 57m | 54.5% |
| 2 | Casdin Capital | USD 483m | 24.2% |
| 3 | Dafna Capital Management | USD 105m | 20.1% |
| 4 | Farallon Capital Management | USD 2.5bn | 11.7% |
| 5 | Baker Bros. Advisors | USD 2.1bn | 10.7% |
| 6 | Rock Springs Capital Management | USD 207m | 10.1% |
| 7 | Boxer Capital Management | USD 94m | 7.1% |
| 8 | Artia Global Partners | USD 35m | 6.4% |
| 9 | Superstring Capital Management | USD 9.6m | 6.0% |
| 10 | Logos Global Management | USD 131m | 5.6% |
Revolution Medicines, Inc. trades under the symbol RVMD on the Nasdaq. Its CUSIP, the code used on Form 13F, is 76155X100.
69 of the 720 hedge fund managers PPLI.com tracks reported Revolution Medicines, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Farallon Capital Management (USD 2.5bn), Baker Bros. Advisors (USD 2.1bn), Casdin Capital (USD 483m), Avoro Capital Advisors (USD 430m) and Holocene Advisors (USD 255m).
69 managers in our coverage reported it, and between them they run 864 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Aihc Capital Management, where the position was 54.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Revolution Medicines, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.